Li Chen

Dr. Li Chen


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in International Journal of Oral Science
Verified
Journal Article
Open access
PDF file
LCLi Chen
Li Chen
YWYu‐Mei Wen
Yu‐Mei Wen
Bacterial biofilms can be viewed as a specific type of persistent bacterial infection. After initial invasion, microbes can attach to living and non‐living surfaces, such as prosthetics and indwelling medical devices, and form a biofilm composed of extracellular polysaccharides, proteins, and other components. In hosts, biofilm formation may trigger drug resistance and inflammation, resulting in persistent infections. The clinical aspects of biofilm formation and leading strategies for biofilm inhibitors will be discussed in this mini‐review.

1 March 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GSGuiqin Sun
Guiqin Sun
XYXiang Yu
Xiang Yu
CBCelimuge Bao
Celimuge Bao
LWLei Wang
Lei Wang
MLMeng Li
Meng Li
LCLi Chen
Li Chen
Peptide:N-glycosidase (PNGase) F, the first PNGase identified in prokaryotic cells, catalyzes the removal of intact asparagine-linked oligosaccharide chains from glycoproteins and/or glycopeptides. Since its discovery in 1984, PNGase F has remained as the sole prokaryotic PNGase. Recently, a novel gene encoding a protein with a predicted PNGase domain was identified from a clinical isolate of Elizabethkingia meningoseptica. In this study, the candidate protein was expressed in vitro and was subjected to biochemical and structural analyses. The results revealed that it possesses PNGase activity and has substrate specificity different from that of PNGase F. The crystal structure of the protein was determined at 1.9 Å resolution. Structural comparison with PNGase F revealed a relatively larger glycan-binding groove in the catalytic domain and an additional bowl-like domain with unknown function at the N terminus of the candidate protein. These structural and functional analyses indicated that the candidate protein is a novel prokaryotic N-glycosidase. The protein has been named PNGase F-II.

21 January 2020 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
KAKuerbanjiang Abuduxikuer
Kuerbanjiang Abuduxikuer
LZLin Zou
Lin Zou
LWLei Wang
Lei Wang
LCLi Chen
Li Chen
JWJianshe Wang
Jianshe Wang

1 January 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TLTiansheng Li
Tiansheng Li
MLMengjie Li
Mengjie Li
LHLinlin Hou
Linlin Hou
YGYameng Guo
Yameng Guo
LWLei Wang
Lei Wang
LCLi Chen
Li Chen
All reported α-L-fucosidases catalyze the removal of nonreducing terminal L-fucoses from oligosaccharides or their conjugates, while having no capacity to hydrolyze core fucoses in glycoproteins directly. Here, we identified an α-fucosidase from the bacterium Elizabethkingia meningoseptica with catalytic activity against core α-1,3-fucosylated substrates and named it core fucosidase I (cFase I). Using site-specific mutational analysis, we found that three acidic residues (Asp-242, Glu-302, and Glu-315) in the predicted active pocket are critical for cFase I activity, with Asp-242 and Glu-315 acting as a pair of classic nucleophile and acid/base residues and Glu-302 acting in an as yet undefined role. These findings suggest a catalytic mechanism for cFase I that is different from known α-fucosidase catalytic models. In summary, cFase I exhibits glycosidase activity that removes core α-1,3 fucoses from substrates, suggesting cFase I as a new tool for glycobiology, especially for studies of proteins with core fucosylation.

25 June 2015 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
GSGuiqin Sun
Guiqin Sun
LWLei Wang
Lei Wang
CBCelimuge Bao
Celimuge Bao
TLTiansheng Li
Tiansheng Li
LMLili Ma
Lili Ma
LCLi Chen
Li Chen
An Elizabethkingia meningoseptica infection was detected at the end stage of a patient with T-cell non-Hodgkin's lymphoma. The complete genome of this isolated strain, FMS-007, was generated in one contig with a total size of 3,938,967 bp. A preliminary screening indicated that the genome contains drug resistance genes to aminoglycosides and β-lactams. A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (CRISPR/Cas) system with 16 direct repeats and 15 spacers was identified.

15 January 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YTYongliang Tong
Yongliang Tong
RCRunqiu Chen
Runqiu Chen
XLXinrong Lu
Xinrong Lu
CCCuiying Chen
Cuiying Chen
GSGuiqin Sun
Guiqin Sun
LCLi Chen
Li Chen